Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
about
Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signalsIdentification of a negative allosteric site on human α4β2 and α3β4 neuronal nicotinic acetylcholine receptorsThe regulation of N-methyl-D-aspartate receptors by Src kinase.Discovery of Novel α4β2 Neuronal Nicotinic Receptor Modulators through Structure-Based Virtual Screening.Activation of functional α7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596Targeting Abeta and tau in Alzheimer's disease, an early interim reportThe nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisitedCurrent and emerging drug treatment options for Alzheimer's disease: a systematic review.Nicotine as a potential neuroprotective agent for Parkinson's disease.Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes.Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptorsA type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats.Two novel α7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in mice.Conotoxins that confer therapeutic possibilities.Arrhythmogenic Risk Assessment Following Four-Week Pretreatment With Nicotine and Black Tea in RatThe Yin and Yang of Nicotine: Harmful during Development, Beneficial in Adult Patient Populations.Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study).Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human Subjectsα4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats.Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's diseaseThe therapeutic promise of positive allosteric modulation of nicotinic receptors.ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.Can nicotine be used medicinally in Parkinson's disease?Possible contributions of a novel form of synaptic plasticity in Aplysia to reward, memory, and their dysfunctions in mammalian brain.Effect of nicotine on L-dopa-induced dyskinesia in animal models of Parkinson's disease: a systematic review and meta-analysis.The ongoing pursuit of neuroprotective therapies in Parkinson disease.Pharmacology of Src family kinases and therapeutic implications of their modulators.Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson's Disease.Regulation of Cigarette Smoke Induction of IL-8 in Macrophages by AMP-activated Protein Kinase Signaling.Neuroactive alkaloids that modulate the neuronal nicotinic receptor and provide neuroprotection in an Alzheimer's disease model: the case of Teline monspessulana.The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.Neuroprotection by nicotine against colchicine-induced apoptosis is mediated by PI3-kinase--Akt pathways.Two galantamine titration regimens in patients switched from donepezil.Lifetime cigarette smoking is associated with striatal volume measures.
P2860
Q26861923-37739A03-03B3-4805-A3F7-A5ADF53D070DQ28477118-62A80EEF-A596-438D-9D09-B6A5DADBFDE2Q30010212-54B8B99A-5AD1-42F2-971F-481A024FBA96Q33752770-68B3BE95-AF38-4E4F-8A23-73027D689A4CQ33754362-97EC638A-1D96-42B9-BAF4-EDDFE8A061F8Q33829008-E8A30F06-FBE0-41FF-8B33-5ED3FA31A367Q33887372-B3BD9F0E-2E49-474B-91B9-D8D2D33558B3Q34222721-A73D01A5-09E2-4285-A924-90DE23026F4EQ34281003-7977E092-906F-42E0-8998-D59DBD1CCA41Q34494853-AF7A50C5-F2CC-4CD5-B2F5-E42BBD694DADQ34545452-E648FD85-0B23-43C2-8FEB-624230D0FEC8Q34952107-29B3123C-E6F0-4AFC-AB66-EDDEBC1808D1Q35548484-E4E928B1-3A9E-4C6F-B99D-569F8A56CBD9Q36096681-4BAF8122-41D3-4EEF-93CA-26C2C38915AFQ36107214-20878527-96BA-4559-997A-A3034EAFA382Q36302232-6400F7F9-63D0-4F6A-8493-166FC564EB5AQ36496748-2E1E2663-763F-4490-BFDF-746A255FE58BQ36600684-CF3F0BD4-5B9A-423B-9E8E-D100D093F118Q36936930-52411C31-75EA-4CF7-A222-D1EE6E5859A4Q37209730-4650BA4B-3C13-411A-BE86-FF26740F4BE2Q37695734-FD2A1BEF-F630-4472-AFE2-952D60D1FA08Q37708588-9F94AA98-32E4-4714-8E05-73026F6ECCF2Q37960523-DF310711-691C-45AF-BF09-079501D83408Q38139358-EC9BCFEF-D6E0-471F-940A-BCE822A3C6F2Q38186596-170F33A5-1523-43E2-9F74-4D77A262984CQ38275171-A1ED88B0-9142-4699-9BEA-0A0A2EEE611DQ38302202-3CE13829-A073-4FBD-A217-AFEE6DEE3128Q38532889-94C7526E-1AD5-418F-855C-B30AC260CF93Q38629277-1ADCD585-BAFC-4501-8A4B-95750854F7E7Q38928842-E81C729B-9438-4A90-B423-B5F956FC2387Q41874171-B4A291BC-9071-4660-8337-5D9D44660118Q42094999-179E3D2D-F480-4401-987C-00CD973F16EBQ43425999-F623C239-82D7-4B62-A5EE-AEF931E3EABEQ50783671-916ABDDD-B481-4E22-9338-C6C913FB3305Q51810046-445436D3-11E8-4F9C-B9F3-2ED43EAEE77A
P2860
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@ast
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@en
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@nl
type
label
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@ast
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@en
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@nl
prefLabel
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@ast
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@en
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@nl
P356
P1476
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
@en
P2093
Shun Shimohama
P304
P356
10.1248/BPB.32.332
P577
2009-03-01T00:00:00Z